Identification of Factors Involved in the Anti-Tumor Activity of Carnosine on Glioblastomas Using a Proteomics Approach

REFERENCES

• Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P. The 2007 WHO classification of tumors of the central nervous system. Acta Neuropathol 2007;114:97–109.
   PubMed Web of Science ®Google Scholar
• Brown M, Schrot R, Bauer K, LeTendre D. Incidence of first primary central nervous system tumors in California, 2001–2005. J Neuro-Oncol 2009;94:249–261.
   PubMed Web of Science ®Google Scholar
• Sarin H. Recent progress towards development of effective systemic chemotherapy for the treatment of malignant brain tumors. J Transl Med 2009;7:77.
   PubMed Web of Science ®Google Scholar
• Stupp R, Mason WP, Van Den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987–996.
   PubMed Web of Science ®Google Scholar
• Laws ER, Parney IF, Huang W, Anderson F, Morris AM, Asher A, Lillehei KO, Bernstein M, Brem H, Sloan A, Berger MS, Chang S. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg 2003;99:467–473.
   PubMed Web of Science ®Google Scholar
• Bansal K, Liang ML, Rutka JT. Molecular biology of human gliomas. Technol Cancer Res Treat 2006;5:185–194.
   PubMed Web of Science ®Google Scholar
• Renner C, Seyffarth A, de Arriba S, Meixensberger J, Gebhardt R, Gaunitz F. Carnosine inhibits growth of cells isolated from human glioblastoma multiforme. Int J Pept Res Ther 2008;14:127–135.
   Web of Science ®Google Scholar
• Renner C, Zemitzsch N, Fuchs B, Geiger KD, Hermes M, Hengstler J, Gebhardt R, Meixensberger J, Gaunitz F. Carnosine retards tumor growth in vivo in an NIH3T3-HER2/neu mouse model. Mol Cancer 2010;9:2.
   PubMed Web of Science ®Google Scholar
• Gulewitsch W, Amiradzibi S. Ueber das Carnosin; eine neue organische Base des Fleischextraktes. Ber Deut Chem Ges 1900; 33:1902–1903.
   Google Scholar
• Mannion AF, Jakeman PM, Dunnett M, Harris RC, Willan PL. Carnosine and anserine concentrations in the quadriceps femoris muscle of healthy humans. Eur J Appl Physiol Occup Physiol 1992;64:47–50.
   PubMed Web of Science ®Google Scholar
• Boldyrev AA. Problems and perspectives in studying the biological role of carnosine. Biochemistry (Mosc) 2000;65:751–756.
   PubMed Web of Science ®Google Scholar
• Guiotto A, Calderan A, Ruzza P, Borin G. Carnosine and carnosine-related antioxidants: a review. Curr Med Chem 2005;12:2293–2315.
   PubMed Web of Science ®Google Scholar
• Smith EC. The buffering of muscle in rigor; protein, phosphate and carnosine. J Physiol 1938;92:336–343.
   PubMedGoogle Scholar
• Baran EJ. Metal complexes of carnosine. Biochemistry (Mosc) 2000;65:789–797.
   PubMed Web of Science ®Google Scholar
• Nadi NS, Hirsch JD, Margolis FL. Laminar distribution of putative neurotransmitter amino acids and ligand binding sites in the dog olfactory bulb. J Neurochem 1980;34:138–146.
   PubMed Web of Science ®Google Scholar
• Kohen R, Yamamoto Y, Cundy KC, Ames BN. Antioxidant activity of carnosine, homocarnosine, and anserine present in muscle and brain. Proc Natl Acad Sci U S A 1988;85:3175–3179.
   PubMed Web of Science ®Google Scholar
• Gallant S, Semyonova M, Yuneva M. Carnosine as a potential anti-senescence drug. Biochemistry (Mosc) 2000;65:866–868.
   PubMed Web of Science ®Google Scholar
• Boldyrev A, Song R, Lawrence D, Carpenter DO. Carnosine protects against excitotoxic cell death independently of effects on reactive oxygen species. Neuroscience 1999;94:571–577.
   PubMed Web of Science ®Google Scholar
• Reddy VP, Garrett MR, Perry G, Smith MA. Carnosine: a versatile antioxidant and antiglycating agent. Sci Aging Knowledge Environ 2005;18:e12.
   Google Scholar
• Renner C, Asperger A, Seyffarth A, Meixensberger J, Gebhardt R, Gaunitz F. Carnosine inhibits ATP production in cells from malignant glioma. Neurol Res 2010;32:101–105.
   PubMed Web of Science ®Google Scholar
• Severina IS, Bussygina OG, Pyatakova NV. Carnosine as a regulator of soluble guanylate cyclase. Biochemistry (Mosc) 2000;65:783–788.
   PubMed Web of Science ®Google Scholar
• Ito-Kato E, Suzuki N, Maeno M, Takada T, Tanabe N, Takayama T, Ito K, Otsuka K. Effect of carnosine on runt-related transcription factor-2/core binding factor alpha-1 and Sox9 expressions of human periodontal ligament cells. J Periodontal Res 2004;39:199–204.
   PubMed Web of Science ®Google Scholar
• Blum H, Beier H, Gross HJ. Improved silver staining of plant-proteins, RNA and DNA in polyacrylamide gels. Electrophoresis 1987;8:93–99.
   Web of Science ®Google Scholar
• Mortz E, Krogh TN, Vorum H, Gorg A. Improved silver staining protocols for high sensitivity protein identification using matrix-assisted laser desorption/ionization-time of flight analysis. Proteomics 2001;1:1359–1363.
   PubMed Web of Science ®Google Scholar
• Pruitt KD, Tatusova T, Maglott DR. NCBI reference sequences (Ref Seq): a curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res 2007;35:D61–D65.
   PubMed Web of Science ®Google Scholar
• Stupp R, Hegi ME, Mason WP, Van Den Bent MJ, Taphoorn MJB, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009;10:459–466.
   PubMed Web of Science ®Google Scholar
• Fountoulakis M. Application of proteomics technologies in the investigation of the brain. Mass Spectrom Rev 2004;23:231–258.
   PubMed Web of Science ®Google Scholar
• Badenas C, To-Figueras J, Phillips JD, Warby CA, Munoz C, Herrero C. Identification and characterization of novel uroporphyrinogen decarboxylase gene mutations in a large series of porphyria cutanea tarda patients and relatives. Clin Genet 2009;75:346–353.
   PubMed Web of Science ®Google Scholar
• Navone NM, Polo CF, Frisardi AL, Andrade NE, Battle AM. DEL C. Heme Biosynthesis in human breast cancer—mimetic in vitro studies and some heme enzymic activity levels. Int J Biochem 1990;22:1407–1411.
   PubMedGoogle Scholar
• Vargas PD, Furuyama K, Sassa S, Shibahara S. Hypoxia decreases the expression of the two enzymes responsible for producing linear and cyclic tetrapyrroles in the heme biosynthetic pathway. FEBS J 2008;275:5947–5959.
   PubMed Web of Science ®Google Scholar
• Samland AK, Sprenger GA. Transaldolase: from biochemistry to human disease. Int J Biochem Cell 2009;41:1482–1494.
   PubMed Web of Science ®Google Scholar
• Wamelink M, Struys E, Jakobs C. The biochemistry, metabolism and inherited defects of the pentose phosphate pathway: a review. J Inherit Metab Dis 2008;31:703–717.
   PubMed Web of Science ®Google Scholar
• Ramos-Montoya A, Lee WNP, Bassilian S, Lim S, Trebukhina RV, Kazhyna MV, Ciudad CJ, Noe V, Centelles JJ, Cascante M. Pentose phosphate cycle oxidative and nonoxidative balance: a new vulnerable target for overcoming drug resistance in cancer. Int J Cancer 2006;119:2733–2741.
   PubMed Web of Science ®Google Scholar
• Kira Y, Nishikawa M. The identification and characterization of a new GTP-binding protein (Gbp45) involved in cell proliferation and death related to mitochondrial function. Cell Mol Biol Lett 2008;13:570–584.
   PubMed Web of Science ®Google Scholar
• Koller-Eichhorn R, Marquardt T, Gail R, Wittinghofer A, Kostrewa D, Kutay U, Kambach C. Human OLA1 defines an ATPase subfamily in the Obg family of GTP-binding proteins. J Biol Chem 2007;282:19928–19937.
   PubMedGoogle Scholar
• Zhang J, Rubio V, Lieberman MW, Shi ZZ. OLA1, an Obg-like ATPase, suppresses antioxidant response via nontranscriptional mechanisms. Proc Natl Acad Sci U S A 2009;106:15356–15361.
   Google Scholar
• Zhang JW, Rubio V, Zheng S, Shi ZZ. Knockdown of OLA1, a regulator of oxidative stress response, inhibits motility and invasion of breast cancer cells. J Zhejiang Univ-Sci B 2009;10:796–804.
   PubMed Web of Science ®Google Scholar
• Borges JC, Fischer H, Craievich AF, Hansen LD, Ramos CHI. Free human mitochondrial GrpE is a symmetric dimer in solution. J Biol Chem 2003;278:35337–35344.
   PubMed Web of Science ®Google Scholar
• Sherman M, Multhoff G. Heat shock proteins in cancer. Ann N Y Acad Sci 2007;1113:192–201.
   PubMed Web of Science ®Google Scholar
• Graner MW, Raynes DA, Bigner DD, Guerriero V. Heat shock protein 70-binding protein 1 is highly expressed in high-grade gliomas, interacts with multiple heat shock protein 70 family members, and specifically binds brain tumor cell surfaces. Cancer Sci 2009;100:1870–1879.
   PubMed Web of Science ®Google Scholar
• Takayama S, Xie ZH, Reed JC. An evolutionarily conserved family of Hsp70/Hsc70 molecular chaperone regulators. J Biol Chem 1999;274:781–786.
   PubMed Web of Science ®Google Scholar
• Ueda K, Kosako H, Fukui Y, Hattori S. Proteomic identification of Bcl2-associated athanogene 2 as a novel MAPK-activated protein kinase 2 substrate. J Biol Chem 2004;279:41815–41821.
   PubMed Web of Science ®Google Scholar
• Arndt V, Daniel C, Nastainczyk W, Alberti S, Hohfeld J. BAG-2 acts as an inhibitor of the chaperone-associated ubiquitin ligase CHIP. Mol Biol Cell 2005;16:5891–5900.
   PubMed Web of Science ®Google Scholar
• Dai Q, Qian SB, Li HH, McDonough H, Borchers C, Huang D, Takayama S, Younger JM, Ren HY, Cyr DM, Patterson C. Regulation of the cytoplasmic quality control protein degradation pathway by BAG2. J Biol Chem 2005;280:38673–38681.
   PubMed Web of Science ®Google Scholar
• Luo W, Zhong J, Chang R, Hu H, Pandey A, Semenza GL. HSP70 and CHIP selectively mediate ubiquitination and degradation of hypoxia-incucible factor (HIF)-1α but not HIF-2α. J Bol Chem 2009;582:3663–1563.
   Google Scholar
• Hohfeld J, Jentsch S. GrpE-like regulation of the Hsc70 chaperone by the anti-apoptotic protein BAG-1. Embo J 1997;16:6209–6216.
   PubMed Web of Science ®Google Scholar
• Tsuchiya H, Iseda T, Hino O. Identification of a novel protein (VBP-1) binding to the vonHippel-Lindau (VHL) tumor suppressor gene product. Cancer Res 1996;56:2881–2885.
   PubMed Web of Science ®Google Scholar
• Mole DR, Ratcliffe PJ. Cellular oxygen sensing in health and disease. Ped Nephrol 2008;23:681–694.
   PubMed Web of Science ®Google Scholar
• Sun X, Liu M, Wei Y, Liu F, Zhi X, Xu R, Krissansen GW. Overexpression of von Hippel-Lindau tumor suppressor protein and antisense HIF-1 alpha eradicates gliomas. Cancer Gene Ther 2006;13:428–435.
   PubMed Web of Science ®Google Scholar
• Hervouet E, Cizkova A, Demont J, Vojtiskova A, Pecina P, Hal NLWF, Keijer J, Simonnet H, Ivanek R, Kmoch S, Godinot C, Houstek J. HIF and reactive oxygen species regulate oxidative phosphorylation in cancer. Carcinogenesis 2008;29:1528–1537.
   PubMed Web of Science ®Google Scholar
• Warburg O, Posener K, Negelein E. Ueber den Stoffwechsel der Carcinomzelle. Biochem Z 1924;152:309–344.
   Google Scholar
• Bharadwaj LA, Davies GF, Xavier IJ, Ovsenek N. L-carnosine and verapamil inhibit hypoxia-induced expression of hypoxia inducible factor (HIF-1 alpha) in H9c2 cardiomyoblasts. Pharmacol Res 2002;45:175–181.
   PubMed Web of Science ®Google Scholar